2m 2m 2m 2m 2m 2m 2m
Omeros (OMER)
NASDAQ
$10.15-$0.11 (-1.07%)
Price as of Jun 03, 2026 6:49 PM EDT- $799.0MMarket Cap
- 226.75%1-Year Change
- BiotechnologyIndustry
Omeros (OMER)
$10.15-$0.11 (-1.07%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cost of Revenue | N/A N/A | N/A N/A | 0 -100.00% | 30.6M N/A | |
Gross Profit | 0 N/A | 0 N/A | 0 -100.00% | 80.1M N/A | |
Sales and Marketing Expense | 41.5M -16.56% | 49.7M +0.15% | 49.7M +1,451.88% | 3.2M -58.97% | |
Research and Development Expense | -81.3M -31.98% | -119.5M +4.05% | -114.9M +1.91% | -112.7M -5.10% | |
Depreciation and Amortization Expense | 964,000 +1.47% | 950,000 +3.26% | 920,000 -3.36% | 952,000 -31.31% | |
Total Operating Expenses | 122.8M -27.45% | 169.3M +2.87% | 164.5M +0.70% | 163.4M -5.89% | |
Operating Profit | -122.8M -27.45% | -169.3M +2.87% | -164.5M +0.70% | -163.4M -5.89% | |
Interest Income | 4.1M -63.77% | 11.3M -30.83% | 16.3M +302.31% | 4.1M N/A | |
Interest Expense | -7.9M -47.47% | -15.0M -51.37% | -30.8M +35.86% | -22.7M +15.42% | |
Interest Income and Expense and Net | -3.8M +2.38% | -3.7M -74.51% | -14.5M -22.20% | -18.6M -5.23% | |
Total Nonoperating Income and Expense | 14.3M -4.87% | 15.0M -51.37% | 30.8M +35.86% | 22.7M +1,204.71% | |
Income before Taxes | -2.8M -98.35% | -169.3M +2.87% | -164.5M -9.61% | -182.0M -4.97% | |
Income Taxes | 2.0M -12.71% | 2.3M N/A | 0 N/A | 0 N/A | |
Extraordinary Items | 0 N/A | 0 N/A | 0 N/A | N/A N/A | |
Net Income | -3.4M -97.86% | -156.8M +33.11% | -117.8M -348.46% | 47.4M -75.59% | |
Net Income from Continuing Operations Applicable to Common | -4.8M -97.37% | -182.6M +4.41% | -174.9M -3.91% | -182.0M -4.97% | |
Basic EPS and Net Income | -0.05 -98.15% | -2.70 +43.62% | -1.88 -347.37% | 0.76 -75.64% | |
Diluted EPS and Net Income | -0.05 -98.15% | -2.70 +43.62% | -1.88 -347.37% | 0.76 -75.64% | |
Basic Weighted Average Shares | 63.5M +9.18% | 58.2M -7.28% | 62.7M +0.003% | 62.7M +0.63% | |
Diluted Weighted Average Shares | 63.5M +9.18% | 58.2M -7.28% | 62.7M +0.003% | 62.7M +0.63% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 9.7M +184.12% | 3.4M -52.15% | 7.1M -35.46% | 11.0M -89.08% | |
Short-Term Investments | 162.1M +86.95% | 86.7M -47.35% | 164.7M -10.42% | 183.9M +225.74% | |
Cash and Cash Equivalents and Short-Term Investments | 171.8M +90.61% | 90.1M -47.55% | 171.8M -11.84% | 194.9M +23.94% | |
Total Current Assets | 215.7M +60.80% | 134.1M -38.45% | 217.9M -50.84% | 443.2M +78.80% | |
Accumulated Depreciation | 12.0M +8.71% | 11.1M +8.11% | 10.2M +7.26% | 9.5M +5.70% | |
Property and Plant and Equipment and Net | 1.8M -33.98% | 2.7M +37.33% | 1.9M +30.70% | 1.5M -13.81% | |
Total Long-Term Assets | 1.8M -33.98% | 2.7M +37.33% | 1.9M N/A | N/A N/A | |
Total Assets | 325.6M +17.52% | 277.1M -26.75% | 378.3M -35.99% | 591.0M +40.95% | |
Income Taxes Payable | 6.1M N/A | 0 -100.00% | 5.3M +9.14% | 4.9M +1,523.67% | |
Total Short-Term Debt | 0 N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 78.1M -1.84% | 79.5M +49.16% | 53.3M -60.91% | 136.4M +163.34% | |
Total Long-Term Debt | 0 -100.00% | 69.4M -67.44% | 213.2M -45.45% | 390.8M +0.47% | |
Total Long-Term Liabilities | 157.2M +30.88% | 120.1M -52.46% | 252.6M -30.44% | 363.1M -3.35% | |
Total Liabilities | 78.1M -1.84% | 79.5M +49.16% | 53.3M -60.91% | 136.4M +163.34% | |
Retained Earnings | -913.7M +0.37% | -910.3M +20.81% | -753.5M +18.53% | -635.7M -6.94% | |
Total Stockholders Equity | -121.2M -33.61% | -182.6M +630.93% | -25.0M -129.16% | 85.7M +260.32% | |
Total Shares Outstanding | 71.7M +23.48% | 58.0M -5.05% | 61.1M -2.71% | 62.8M +0.32% | |
Cash Flow | |||||
Cash from Operating Activities | -116.1M -21.98% | -148.8M -299.13% | 74.7M +186.41% | -86.5M -21.18% | |
Capital Expenditures | 65,000 -60.61% | 165,000 -61.27% | 426,000 +276.99% | 113,000 -59.21% | |
Cash from Investing Activities | 164.5M +100.11% | 82.2M +199.47% | 27.5M +121.52% | -127.6M -165.85% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -42.2M -167.06% | 62.9M +159.27% | -106.1M -185.38% | 124.2M +1,866.26% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Return on Assets | -1.11% -97.68% | -47.86% +96.86% | -24.31% -358.97% | 9.39% -85.49% | |
Return on Equity | 2.21% -98.54% | 151.08% +138.92% | -388.17% -548.06% | 86.63% +121.63% | |
Revenue Growth | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Current Ratio | 2.76 +63.82% | 1.69 -58.73% | 4.09 +25.75% | 3.25 -32.10% | |
Cash Ratio | 0.12 +189.02% | 0.04 -67.89% | 0.13 +65.18% | 0.08 -95.85% | |
Debt-to-Equity Ratio | 0.00 N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.00 N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow